LLY

764

-0.29%↓

JNJ

176.92

-0.08%↓

ABBV

220.66

+1.71%↑

UNH

339.83

-0.79%↓

AZN

77.68

-0.21%↓

LLY

764

-0.29%↓

JNJ

176.92

-0.08%↓

ABBV

220.66

+1.71%↑

UNH

339.83

-0.79%↓

AZN

77.68

-0.21%↓

LLY

764

-0.29%↓

JNJ

176.92

-0.08%↓

ABBV

220.66

+1.71%↑

UNH

339.83

-0.79%↓

AZN

77.68

-0.21%↓

LLY

764

-0.29%↓

JNJ

176.92

-0.08%↓

ABBV

220.66

+1.71%↑

UNH

339.83

-0.79%↓

AZN

77.68

-0.21%↓

LLY

764

-0.29%↓

JNJ

176.92

-0.08%↓

ABBV

220.66

+1.71%↑

UNH

339.83

-0.79%↓

AZN

77.68

-0.21%↓

Search

West Pharmaceutical Services Inc

Deschisă

SectorSănătate

258.29 0.19

Rezumat

Modificarea prețului

24h

Curent

Minim

256.18

Maxim

261.62

Indicatori cheie

By Trading Economics

Venit

42M

132M

Vânzări

68M

766M

P/E

Medie Sector

37.897

35.664

EPS

1.45

Randament dividend

0.33

Marjă de profit

17.202

Angajați

10,600

EBITDA

48M

199M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+23.58% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

0.33%

3.12%

Următoarele câștiguri

23 oct. 2025

Data viitoare de dividende

19 nov. 2025

Următoarea dată ex-dividende

12 nov. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

3.1B

18B

Deschiderea anterioară

258.1

Închiderea anterioară

258.29

Sentimentul știrilor

By Acuity

50%

50%

185 / 371 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Strong Bullish Evidence

West Pharmaceutical Services Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

16 sept. 2025, 17:03 UTC

Principalele dinamici ale pieței

BrainsWay Shares Rise on FDA Clearance of Major Depressive Disorder Treatment

16 sept. 2025, 16:49 UTC

Principalele dinamici ale pieței
Achiziții, Fuziuni, Preluări

GD Culture Shares Drop After Deal for Pallas Capital

16 sept. 2025, 16:11 UTC

Principalele dinamici ale pieței

Corbus Shares Rise on FDA Fast-Track Designation for Cancer Drug

16 sept. 2025, 23:40 UTC

Market Talk

Nikkei May Decline as Yen Strengthens -- Market Talk

16 sept. 2025, 23:34 UTC

Market Talk

Gold Edges Higher Ahead of FOMC Decision -- Market Talk

16 sept. 2025, 23:20 UTC

Market Talk

Restaurant Brands NZ Can Outperform When Cycle Turns -- Market Talk

16 sept. 2025, 21:10 UTC

Achiziții, Fuziuni, Preluări

U.S. Investors, Trump Close In on TikTok Deal With China -- WSJ

16 sept. 2025, 20:51 UTC

Market Talk

U.S. Home Sales, New Home Listings Fall in August -- Market Talk

16 sept. 2025, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

16 sept. 2025, 20:50 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Basic Materials Roundup: Market Talk

16 sept. 2025, 20:25 UTC

Câștiguri

The AI Trade Has Stocks Near Highs Again. Some Tech Names Remain on the Sidelines -- Barrons.com

16 sept. 2025, 20:24 UTC

Câștiguri

These Stocks Moved the Most Today: Oracle, Tesla, Alphabet, Dave & Buster's, Chipotle, and More -- Barrons.com

16 sept. 2025, 19:19 UTC

Market Talk

U.S. Natural Gas Futures Extend Winning Streak -- Market Talk

16 sept. 2025, 18:52 UTC

Market Talk

Oil Futures Advance on Russia Concerns, Weak Dollar -- Market Talk

16 sept. 2025, 18:44 UTC

Market Talk

Global Equities Roundup: Market Talk

16 sept. 2025, 18:44 UTC

Market Talk

EssilorLuxottica Well-Positioned in Growing Smart-Glasses Market -- Market Talk

16 sept. 2025, 18:40 UTC

Achiziții, Fuziuni, Preluări

Details Emerge on U.S.-China TikTok Deal -- WSJ

16 sept. 2025, 18:38 UTC

Market Talk

Meta Seen With Long-Term Opportunity to Lead in Smart Glasses -- Market Talk

16 sept. 2025, 18:19 UTC

Market Talk

Gold Settles at New High Ahead of Fed Decision -- Market Talk

16 sept. 2025, 18:01 UTC

Market Talk

U.S. Dollar Weakness Supports Oil's Gains -- Market Talk

16 sept. 2025, 17:34 UTC

Market Talk

Any Question the Bank of Canada Will Cut Now Look to Have Vanished -- Market Talk

16 sept. 2025, 16:53 UTC

Câștiguri

Software Companies Are Fighting Back With AI. The Stocks Are Still Hurting. -- Barrons.com

16 sept. 2025, 16:20 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Basic Materials Roundup: Market Talk

16 sept. 2025, 16:15 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Global Commodities Roundup: Market Talk

16 sept. 2025, 16:09 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Global Energy Roundup: Market Talk

16 sept. 2025, 16:09 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Canada Industry Minister to Meet Mining CEOs on Merger -- Market Talk

16 sept. 2025, 15:35 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

16 sept. 2025, 15:35 UTC

Market Talk

Gold Soars Past $3,700 Ahead of Fed Decision -- Market Talk

16 sept. 2025, 15:22 UTC

Market Talk

More Investors Think Dollar is Overvalued in Latest BofA Survey -- Market Talk

16 sept. 2025, 15:21 UTC

Market Talk

Sterling Considered Most Overvalued in Nearly 10 Years -- Market Talk

Comparație

Modificare preț

West Pharmaceutical Services Inc Așteptări

Obiectiv de preț

By TipRanks

23.58% sus

Prognoză pe 12 luni

Medie 318.25 USD  23.58%

Maxim 350 USD

Minim 245 USD

În baza a 9 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruWest Pharmaceutical Services Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

9 ratings

8

Cumpărare

1

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

213.26 / 219.27Suport & Rezistență

Termen scurt

Strong Bullish Evidence

Termen mediu

Bearish Evidence

Termen lung

Bearish Evidence

Sentiment

By Acuity

185 / 371 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
help-icon Live chat